Aashka Hospitals Limited
BSE: AASHKA · Hospital · sector
₹99.25BSE close 2026-10-26
Key numbers
Market cap₹234 cr
Price₹99.25
52w high / low₹108 / ₹59
P/E69.4xSector median 42.5x
P/B2.9xSector median 4.9x
Book value₹33.9
Dividend yield–Sector median 0.17%
ROE4.3%Sector median 12.1%
ROCE6.4%Sector median 13.8%
OPM25.4%Sector median 20.3%
Debt / equity–Sector median 0.24x
EV/EBITDA39.3xSector median 23.6x
Interest cover4.3x
Current ratio2.80x
Sales growth 3y+6.7%Sector median +14.1%
Profit growth 3y–Sector median +14.7%
PEG–
Last 12 months to Mar 2026, Standalone. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 4.3x in the last 12 months.
- Other income was 68% of net profit in the last 12 months.
- No dividend in the last 5 financial years.
- Price ₹99.25 on 2026-10-26: -8.1% from the 52-week high, +68.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹118.65 · low ₹60.00
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 10 | 10 | 13 |
| EBITDA | 1 | 3 | 3 |
| OPM % | 7.0% | 25.9% | 24.9% |
| Other income | 3 | 0 | 2 |
| Net profit | 2 | 1 | 3 |
| EPS (₹) | 0.70 | 0.33 | 1.09 |
Standalone figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 40 | 19 | 23 | 23 | 23 | 23 |
| EBITDA | 8 | 0 | 4 | 5 | 6 | 6 |
| Net profit | 2 | -3 | 2 | 3 | 3 | 3 |
| EPS (₹) | 1.01 | -1.10 | 1.01 | 1.40 | 1.43 | 1.43 |
| Revenue growth | -52.3% | +20.7% | -1.0% | +1.6% | – | |
| Profit growth | -208.4% | – | +38.6% | +2.1% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +6.7% | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -3.3% (2y) | +17.4% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 76 | 80 |
| Cash & equivalents | 3 | 4 |
| Total assets | 116 | 116 |
| Fixed assets | 41 | 40 |
| Investments | 0 | 0 |
| Inventory | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 9 | 8 |
| Cash from investing | -1 | -3 |
| Cash from financing | -7 | -3 |
| Capex | 1 | 3 |
| Free cash flow | 8 | 5 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 4.3% | 4.2% |
| ROCE % | 7.3% | 6.4% |
| Inventory days | 58 | 49 |
| Working capital days | 45 | 172 |
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| AASHKA | ₹234 cr | 69.4x | 2.9x | 4.3% | 6.4% | 25.4% | +6.7% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | AASHKA |
| BSE code | 543346 |
| ISIN | INE0EAX01014 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.